News
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
A recent study discovered that an inexpensive HIV drug could be effective for diabetic people by reversing a complication ...
General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...
More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results